Roche Rejects SQZ’s HPV-16 Programmed, Leaving the Company in a Lurch
Introduction In recent news, Roche, a leading pharmaceutical company, has made the surprising decision to reject SQZ Biotechnologies’ HPV-16 programmed, leaving the latter in a challenging situation. This unexpected development…